KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Depreciation and Depletion (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Depreciation and Depletion for 17 consecutive years, with $108.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion rose 10.2% to $108.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $416.0 million through Dec 2025, up 13.66% year-over-year, with the annual reading at $416.0 million for FY2025, 13.66% up from the prior year.
  • Depreciation and Depletion hit $108.0 million in Q4 2025 for Quest Diagnostics, up from $103.0 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $108.0 million in Q4 2025 to a low of $74.0 million in Q1 2021.
  • Historically, Depreciation and Depletion has averaged $86.8 million across 5 years, with a median of $83.0 million in 2023.
  • Biggest five-year swings in Depreciation and Depletion: rose 23.33% in 2021 and later decreased 3.75% in 2022.
  • Year by year, Depreciation and Depletion stood at $80.0 million in 2021, then dropped by 3.75% to $77.0 million in 2022, then increased by 6.49% to $82.0 million in 2023, then rose by 19.51% to $98.0 million in 2024, then rose by 10.2% to $108.0 million in 2025.
  • Business Quant data shows Depreciation and Depletion for DGX at $108.0 million in Q4 2025, $103.0 million in Q3 2025, and $104.0 million in Q2 2025.